System Upgrade on Tue, May 28th, 2024 at 2am (EDT)
Existing users will be able to log into the site and access content. However, E-commerce and registration of new users may not be available for up to 12 hours.For online purchase, please visit us again. Contact us at customercare@wspc.com for any enquiries.
Bestsellers
Linear Algebra and Optimization with Applications to Machine Learning
Volume I: Linear Algebra for Computer Vision, Robotics, and Machine Learning
by Jean Gallier and Jocelyn Quaintance
Linear Algebra and Optimization with Applications to Machine Learning
Volume II: Fundamentals of Optimization Theory with Applications to Machine Learning
by Jean Gallier and Jocelyn Quaintance
Application of Omics, AI and Blockchain in Bioinformatics Research
edited by Jeffrey J-P Tsai and Ka-Lok Ng
Results: 1 - 1of1
Save this search
Please login to be able to save your searches and receive alerts for new content matching your search criteria.
Two-stage nanoparticle delivery of piperlongumine and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) anti-cancer therapy
Preview AbstractThis study outlines a drug delivery mechanism that utilizes two independent vehicles, allowing for delivery of chemically and physically distinct agents. The mechanism was utilized to deliver a new anti-cancer combination therapy consisting of piperlongumine (PL) and TRAIL to treat PC3 prostate cancer and HCT116 colon cancer cells. PL, a small-molecule hydrophobic drug, was encapsulated in poly (lactic-co-glycolic acid) (PLGA) nanoparticles. TRAIL was chemically conjugated to the surface of liposomes. PL was first administered to sensitize cancer cells to the effects of TRAIL. PC3 and HCT116 cells had lower survival rates in vitro after receiving the dual nanoparticle therapy compared to each agent individually. In vivo testing involved a subcutaneous mouse xenograft model using NOD-SCID gamma mice and HCT116 cells. Two treatment cycles were administered over 48 hours. Higher apoptotic rates were observed for HCT116 tumor cells that received the dual nanoparticle therapy compared to individual stages of the nanoparticle therapy alone.